Key result
Preprocedural NT-proBNP >876.1 pg/mL was an independent predictor of contrast-induced nephropathy non-recovery among patients undergoing percutaneous coronary intervention.
Why the study?
The predictive value of preprocedural NT-proBNP for contrast-induced nephropathy non-recovery and long-term outcomes in patients undergoing PCI remained unclear.
Does elevated preprocedural NT-proBNP predict contrast-induced nephropathy non-recovery and long-term mortality in patients undergoing PCI?
Cohort (n=550)
No
Does elevated preprocedural NT-proBNP predict contrast-induced nephropathy non-recovery and long-term mortality in patients undergoing PCI?
Answers are grounded in this paper and cite their sources.
Elevated preprocedural NT-proBNP (>876.1 pg/mL) is an independent predictor of contrast-induced nephropathy non-recovery and is associated with higher long-term mortality in patients undergoing PCI.
BACKGROUND: Contrast-induced nephropathy (CIN) is a frequent complication in patients undergoing percutaneous coronary intervention (PCI). The degree of recovery of renal function from CIN may affect long-term prognosis. N-terminal pro B-type natriuretic peptide (NT-proBNP) is a simple but useful biomarker for predicting CIN. However, the predictive value of preprocedural NT-proBNP for CIN non-recovery and long-term outcomes in patients undergoing PCI remains unclear. METHODS AND RESULTS: This study prospectively enrolled 550 patients with CIN after PCI between January 2012 and December 2018. CIN non-recovery was defined as persistent serum creatinine >25% or 0.5 mg/dL over baseline from 1 week to 12 months after PCI in patients who developed CIN. CIN non-recovery was observed in 40 (7.3%) patients. Receiver operating characteristic analysis indicated that the best NT-proBNP cut-off value for detecting CIN non-recovery was 876.1 pg/mL (area under the curve 0.768; 95% confidence interval [CI] 0.731-0.803). After adjusting for potential confounders, multivariable analysis indicated that NT-proBNP >876.1 pg/mL was an independent predictor of CIN non-recovery (odds ratio 1.94; 95% CI 1.03-3.75; P=0.0042). Kaplan-Meier curves showed higher rates of long-term mortality among patients with CIN non-recovery than those with CIN recovery (Chi-squared=14.183, log-rank P=0.0002). CONCLUSIONS: Preprocedural NT-proBNP was associated with CIN non-recovery among patients undergoing PCI. The optimal cut-off value for NT-proBNP to predict CIN non-recovery was 876.1 pg/mL.
No takes yet. Share an insight, caveat, or question.
Luo et al. (2022) conducted a cohort in Contrast-induced nephropathy (CIN) (n=550). Preprocedural NT-proBNP >876.1 pg/mL vs. Preprocedural NT-proBNP ≤876.1 pg/mL was evaluated on CIN non-recovery (persistent serum creatinine >25% or 0.5 mg/dL over baseline from 1 week to 12 months after PCI) (OR 1.94, 95% CI 1.03-3.75, p=0.0042). Preprocedural NT-proBNP >876.1 pg/mL was an independent predictor of contrast-induced nephropathy non-recovery among patients undergoing percutaneous coronary intervention.
Synapse has enriched 10 related papers. Consider them for comparative context: